1. Home
  2. SQNS vs AADI Comparison

SQNS vs AADI Comparison

Compare SQNS & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • AADI
  • Stock Information
  • Founded
  • SQNS 2003
  • AADI 2011
  • Country
  • SQNS France
  • AADI United States
  • Employees
  • SQNS N/A
  • AADI N/A
  • Industry
  • SQNS Semiconductors
  • AADI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • AADI Health Care
  • Exchange
  • SQNS Nasdaq
  • AADI Nasdaq
  • Market Cap
  • SQNS 70.9M
  • AADI 59.4M
  • IPO Year
  • SQNS 2011
  • AADI N/A
  • Fundamental
  • Price
  • SQNS $3.01
  • AADI $2.36
  • Analyst Decision
  • SQNS Strong Buy
  • AADI Hold
  • Analyst Count
  • SQNS 1
  • AADI 3
  • Target Price
  • SQNS $7.50
  • AADI $1.75
  • AVG Volume (30 Days)
  • SQNS 168.6K
  • AADI 109.6K
  • Earning Date
  • SQNS 11-05-2024
  • AADI 11-06-2024
  • Dividend Yield
  • SQNS N/A
  • AADI N/A
  • EPS Growth
  • SQNS N/A
  • AADI N/A
  • EPS
  • SQNS 1.65
  • AADI N/A
  • Revenue
  • SQNS $30,555,000.00
  • AADI $25,070,000.00
  • Revenue This Year
  • SQNS $10.14
  • AADI $9.39
  • Revenue Next Year
  • SQNS $8.54
  • AADI $6.15
  • P/E Ratio
  • SQNS $1.78
  • AADI N/A
  • Revenue Growth
  • SQNS N/A
  • AADI 7.80
  • 52 Week Low
  • SQNS $0.85
  • AADI $1.21
  • 52 Week High
  • SQNS $7.43
  • AADI $2.63
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 54.44
  • AADI 58.75
  • Support Level
  • SQNS $2.86
  • AADI $2.25
  • Resistance Level
  • SQNS $3.11
  • AADI $2.45
  • Average True Range (ATR)
  • SQNS 0.20
  • AADI 0.11
  • MACD
  • SQNS -0.03
  • AADI -0.01
  • Stochastic Oscillator
  • SQNS 38.36
  • AADI 39.89

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Share on Social Networks: